Soriano JB et al (2022) A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis 22(4):e102–e107
Davis HE et al (2023) Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 21(3):133–146
Article PubMed PubMed Central CAS Google Scholar
Pinzon RT et al (2022) Persistent neurological manifestations in long COVID-19 syndrome: A systematic review and meta-analysis. J Infect Public Health V 15 n. 8:856–869
Premraj L et al (2022) Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. J Neurol Sci V 434:120162
Lai C-C et al (2023) Long COVID: an inevitable sequela of SARS-CoV-2 infection. J Microbiol, Immunol and Infect 56(1):1–9
Kay LM (2022) COVID-19 and olfactory dysfunction: A looming wave of dementia? J Neurophysiol 128(2):436–444
Article PubMed PubMed Central CAS Google Scholar
Liang F, Wang, De Yun (2021) COVID-19 anosmia: high prevalence, plural neuropathogenic mechanisms, and scarce neurotropism of SARS-CoV-2? Viruses, v. 13, n. 11, p. 2225
Sowa Paweł, Dadok A, Adamczyk-Sowa (2023) Monika. SARS-CoV-2 neurotropism and other possible causes of olfactory disorders in COVID-19. Neurologia i neurochirurgia polska, v. 57, n. 1, p. 36–42
Chen M, Reed RR, Lane AP (2019) Chronic inflammation directs an olfactory stem cell functional switch from neuroregeneration to immune defense. Cell stem cell, v. 25, n. 4, pp. 501–513. e5
Auinger AB et al (2021) Long-term impact of olfactory dysfunction on daily life. Wiener Klinische Wochenschrift 133:1004–1011
Liu DT et al (2022) Olfactory-related quality of life adjustments in smell loss during the Coronavirus-19 pandemic. Am J Rhinology Allergy V 36(2):253–260
Prem B et al (2022) Long-lasting olfactory dysfunction in COVID-19 patients. Eur Arch Oto-Rhino-Laryngol pp 1–8
Speth MM et al (2020) Mood, anxiety and olfactory dysfunction in COVID-19: evidence of central nervous system involvement?. Laryngoscope 130(11):2520–2525
Yom-Tov E, Lekkas D, Jacobson NC (2021) Association of COVID19-induced anosmia and Ageusia with depression and suicidal ideation. J Affect Disorders Rep V 5, p. 100156
Bochicchio V et al (2023) Olfactory-related quality of life impacts psychological distress in people with COVID-19: the affective implications of olfactory dysfunctions. J Affect Disord 323:741–747
Article PubMed CAS Google Scholar
Graves A, Borenstein et al (1999) Impaired olfaction as a marker for cognitive decline: interaction with Apolipoprotein E ε4 status. Neurology V 53 N 7:1480–1480
Doty RL (2017) Olfactory dysfunction in neurodegenerative diseases: is there a common pathological substrate? Lancet Neurol 16(6):478–488
Xydakis MS et al (2021) Post-viral effects of COVID-19 in the olfactory system and their implications. Lancet Neurol V 20:753–761
Laukka EJ et al (2023) Markers of olfactory dysfunction and progression to dementia: A 12-year population-based study. Alzheim & Dementia 19(7):3019–3027
Kay LM (2022) COVID-19 and olfactory dysfunction: a looming wave of dementia?. J Oneurophysiol 128(2):436–444
Lledó GM et al (2022) Post-acute COVID-19 syndrome: a new tsunami requiring a universal case definition. Clin Microbiol Infect 28(3):315–318
Yap A, Che et al (2022) Olfactory dysfunction is associated with mild cognitive impairment in community-dwelling older adults. Front Aging Neurosci V 14:930686
Alemanno F et al (2021) COVID-19 cognitive deficits after respiratory assistance in the subacute phase: A COVID-rehabilitation unit experience. PLoS ONE 16(2):e0246590
Article PubMed PubMed Central CAS Google Scholar
Cacciatore M et al (2022) Neurological and mental health symptoms associated with post-COVID-19 disability in a sample of patients discharged from a COVID-19 ward: A secondary analysis. Int J Environ Res Public Health 19(7):4242
Caspersen IH, Magnus P, Trogstad L (2022) Excess risk and clusters of symptoms after COVID-19 in a large Norwegian cohort. Eur J Epidemiol 37:539–548. https://doi.org/10.1007/s10654-022-00847-8
Article PubMed PubMed Central CAS Google Scholar
Desai DD, Yu SE, Salvatore B, Goldberg Z, Bowers EMR, Moore JA et al (2022) Olfactory and neurological outcomes of SARS-CoV-2 from acute infection to recovery. Front Allergy V 3:1019274. https://doi.org/10.3389/falgy.2022.1019274
Tavares-Júnior JWL, Oliveira DN, Da Silva JBS, Feitosa WLQ, Sousa AVM, Cunha LCV et al (2022) Long-COVID cognitive impairment: cognitive assessment and Apolipoprotein E (APOE) genotyping correlation in a Brazilian cohort. Front Psych 13:947583. https://doi.org/10.3389/fpsyt.2022.947583
Almeria M, Cejudo JC, Sotoca J, Deus J, Krupinski J (2020) Cognitive profile following COVID-19 infection: clinical predictors leading to neuropsychological impairment. Brain Behav Immun Health 9:100163. https://doi.org/10.1016/j.bbih.2020.100163
Article PubMed PubMed Central CAS Google Scholar
Azcue N, Gomez-Esteban JC, Acera M, Tijero B, Fernandez T, Ayo-Mentxakatorre N et al (2022) Brain fog of post-COVID-19 condition and chronic fatigue syndrome, same medical disorder? J Transl Med 20:569. https://doi.org/10.1186/s12967-022-03764-2
Article PubMed PubMed Central CAS Google Scholar
Cecchetti G, Agosta F, Canu E, Basaia S, Barbieri A, Cardamone R et al (2022) Cognitive, EEG, and MRI features of COVID-19 survivors: A 10-month study. J Neurol 269:3400–3412. https://doi.org/10.1007/s00415-022-11047-5
Article PubMed PubMed Central CAS Google Scholar
Chen et al (2022) Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: A meta-analysis and systematic review. J Infect Dis 226:1593–1607
Article PubMed CAS Google Scholar
Damiano RF, Neto DB, Oliveira JVR, Magalhães Santos J, Alves JVR, Guedes BF et al (2023) Association between chemosensory impairment with neuropsychiatric morbidity in post-acute COVID-19 syndrome: results from a multidisciplinary cohort study. Eur Arch Psychiatry Clin Neurosci 273:325–333. https://doi.org/10.1007/s00406-022-01427-3
Delgado-Alonso C, Valles-Salgado M, Delgado-Alvarez A, Yus M, Gomez-Ruiz N, Jorquera M et al (2022) Cognitive dysfunction associated with COVID-19: A comprehensive neuropsychological study. J Psychiatr Res 150:40–46. https://doi.org/10.1016/j.jpsychires.2022.03.033
Article PubMed PubMed Central Google Scholar
Di Stadio A, Brenner MJ, De Luca P, Albanese M, D’Ascanio L, Ralli M et al (2022) Olfactory dysfunction, headache, and mental clouding in adults with long-COVID-19: what is the link between cognition and olfaction? A cross-sectional study. Brain Sci V 12:154. https://doi.org/10.3390/brainsci12020154
Ferrucci R, Dini M, Rosci C, Capozza A, Groppo E, Reitano MR et al (2022) One-year cognitive follow-up of COVID-19 hospitalized patients. Eur J Neurol V 29:2006–2014. https://doi.org/10.1111/ene.15324
Fiorentino J, Payne M, Cancian E, Plonka A, Dumas LE, Chirio D et al (2022) Correlations between persistent olfactory and semantic memory disorders after SARS-CoV-2 infection. Brain Sci V 12:714. https://doi.org/10.3390/brainsci12060714
Jennings G, Monaghan A, Xue F, Duggan E, Romero-Ortuno R (2022) Comprehensive clinical characterisation of brain fog in adults reporting long COVID symptoms. J Clin Med V 11:3440. https://doi.org/10.3390/jcm11123440
Kopishinskaia S, Lapshova D, Sherman M, Velichko I, Voznesensky N, Voznesenskaia V (2021) Clinical features in Russian patients with Covid-associated parosmia/phanthosmia. Psychiatr Danub V 33:130–136
Llana T, Mendez M, Zorzo C, Fidalgo C, Juan MC, Mendez-Lopez M (2022) Anosmia in COVID-19 could be associated with long-term deficits in the consolidation of procedural and verbal declarative memories. Front Neurosci V 16:1082811. https://doi.org/10.3389/fnins.2022.1082811
Raveendran AV, Long (2021) COVID-19: challenges in the diagnosis and proposed diagnostic criteria. Diabetes Metabol Syndrome V 15(1):145
Memória CláudiaM et al (2013) Brief screening for mild cognitive impairment: validation of the Brazilian version of the Montreal cognitive assessment. Int J Geriatric Psychiatry V 28(1):34–40
Nasreddine ZS et al (2005) The Montreal cognitive assessment, moca: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc V 53(4):695–699
Cain WS, Gent JF, Goodspeed RB, Leonard G et al (1988) Evaluation of olfactory dysfunction in the Connecticut chemosensory clinical research center. Laryngoscope 98(1):83–88
Article PubMed CAS Google Scholar
Fenólio, Guilherme HM et al (2022) Validação do teste de Olfato de Connecticut (CCCCC) adaptado Para o Brasil. Braz J Otorhinolaryngol 88:725–732
Comments (0)